Goran Malojcic

Company: Novartis AG

Job title: Group Leader, Biochemistry & Biophysics

Seminars:

Combined Screening and Optimization Approaches Enable Discovery of Highly Selective Kinase Inhibitors 11:00 am

Targeting kinases with specific small molecule inhibitors holds promise for treating diseases with high unmet medical need, but discovering such selective kinase inhibitors remains a major challenge Combined insights from biophysical, biochemical, cellular, and modeling studies, as well as structure-based design enabled the discovery of highly selective compounds with a suitable set of properties for…Read more

day: Day 2